Magnesium sulphate for tetanus
First, they studied tetanus-a disease frequently forgotten, but certainly not gone,3 with an estimated global incidence of a million cases a year.4 Second, they did a randomised trial of a therapeutic intervention for tetanus, which is rare-there have been only nine such trials for tetanus in the pa...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2006-10, Vol.368 (9545), p.1398-1399 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | First, they studied tetanus-a disease frequently forgotten, but certainly not gone,3 with an estimated global incidence of a million cases a year.4 Second, they did a randomised trial of a therapeutic intervention for tetanus, which is rare-there have been only nine such trials for tetanus in the past 30 years.5 Third, they assessed an inexpensive, easily available drug-magnesium sulphate-also a unique feature because too often randomised trials are industry-sponsored research of expensive agents that might be unavailable in some health-care systems. Magnesium sulphate is safe, and reduces the need to use other drugs to control tetanic muscle spasms and autonomic dysfunction: fewer courses of the benzodiazepine midazolam (given for severe spasms), of the curare-like drug pipecuronium, and of the calcium-channel blocker verapamil were given to patients allocated continuous infusions of magnesium sulphate than those allocated placebo. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(06)69445-2 |